The year 2012 is coming to an end, and it's been a big year for generic drugs. It's the year that the most lucrative drug of all time became commoditized. It's the year that Watson bought Actavis for $5.6 billion. And it's the year the FDA released draft guidance for biosimilars regulations. All of these events speak to some of the most important trends in the world of generics — trends that are often interrelated.
Target is looking to compete with the likes of Netflix and Hulu with a video-streaming service it is beta testing with employees, according to published reports.
Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.
Oscar Mayer announced the addition of five new hot dog innovations featuring bacon, sausage, chicken breast, lean and extra lean varieties available this summer.
Cider may be the most exciting new segment in the beer category. A recent report from Mintel indicated that in the United Kingdom, the market penetration of cider is now equal to lager.
Meda Consumer Healthcare is quickly developing a reputation for re-energizing iconic brands across new consumer groups. They've done it with Feosol. And now they're looking to reinvent Geritol.
Hain Celestial Group, the company that makes Celestial Seasonings tea and other products, has purchased organic baby food company Ella's Kitchen Group, the company said.
Healthcare analytics firm IMS Health has acquired social media analytics company Semantelli Corp., saying the purchase would allow it to provide real-time monitoring and delivery of insights into consumer and physician behavior and sentiments.
Drug maker Actavis has acquired rights to a treatment for an experimental bacterial vaginosis from Valeant Pharmaceuticals International for about $55 million, the drug makers said.
A proposal by Canadian drug maker Valeant Pharmaceuticals International to purchase generic drug maker Actavis has fallen through, according to published reports.
It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.
The Jean Coutu Group sold 72.5 million of its 178.4 million shares of Rite Aid stock, according to a Securities and Exchange Commission filing Monday and company announcement Tuesday.
The University of Utah's College of Pharmacy has opened a new research organization designed to encourage collaboration and interaction, according to published reports.
The Council for Responsible Nutrition on Monday named six new members, including Aurora Algae, Nature’s Sources, Reckitt Benckiser, Sirio Pharma, Watson and international member JJ Health.
American Greetings greeting card company has agreed to be taken private by a group led by some of its top executives for about $602 million, the company announced.
About $209.3 million worth of Target's debt has been put up for sale as the company moves to refinance $679 million worth of debt due between 2028 and 2031, the mass merchandise retailer said.
Pharmaceutical vending machine maker Medbox has bought a 50% stake in a Michigan-based company that has developed an automated medicine dispensing machine, Medbox said Friday.
Target has purchased two online retailers of cooking equipment in a move designed to expand its cooking and kitchenware business, said the mass merchandise retailer, which has lately made major investments in multichannel retailing.